Researchers have identified a key role microglia play in melanoma brain metastases progression and mechanisms to target them.
Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...
New research published in Nature Communications reveals how cancer cells are altered by their surroundings, enabling them to ...
A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great interest for cancer medicine because a change of identity of cells has come into focus as a ...
6d
StudyFinds on MSNNew light-activated salt treatment targets aggressive breast cancer with precisionDiscover the latest advancements in breast cancer treatment combining specialized salt and near-infrared light to target ...
18h
News Medical on MSNAston University collaborates on injectable paste for bone cancer treatmentAston University is collaborating in research to develop an injectable paste which could treat bone cancer.
During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON ...
2d
Medpage Today on MSNAdd-On Cemiplimab Shows Promise as First-Line Treatment for Penile CancerSAN FRANCISCO -- A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in patients ...
Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...
13h
Stockhead on MSNBiocurious: Cashed up and pursuing the ‘c’ word, Imugene is on the verge of transforming cancer immunotherapyImugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.
Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results